Excerpts

Analysis using a two-tailed Fisher’s exact test of SMM compared to MGUS shows a trend toward significance (3/10 vs. 0/12; p = 0.08).

However, although the correlation between CPM and NRS changes showed a trend towards significance, it was not found to be significant (correlation coefficient ρ = −0.16, p -value = 0.08). 4.

In patients gaining weight, for both 25[OH]D deficient and insufficient groups the risk was consistently elevated with only a trend toward significance ( p = 0.08 and p = 0.07) ( Table 2 ).

At +100 days post-HSCT, the AUTO group showed a trend towards enhanced recovery compared to the ALLO group for the 6MWT (mean difference (MD) = 99.20, 95% CI (−12.01, 210.40), p = 0.08) and the 30CST (MD = 3.42, 95% CI (−0.50, 7.33), p = 0.09).

Other variables being associated with an inferior TTT were high (>4) AAA risk-score category (HR 5.9, p < 0.001), age >70 years (HR 3.34, p < 0.001), presence of CKD (HR 2.07, p = 0.045), high (>12.7 × 10 9 /L) WBC (HR 1.96, p = 0.028), high (>5.8 × 10 9 /L) ANC (HR 2.1, p = 0.025), low (≤2 × 10 9 ) ALC (HR 1.88, p = 0.028), high (>2.8) NLR (HR 2.17, p = 0.011), and high (>221) PLR (HR 2.28, p = 0.004), whereas the ELN risk score was of borderline significance (HR 1.68, p = 0.080).

A mildly significant difference in MCMS between time was found ( p = 0.08).

♀ 11.5 ± 5.2, p < 0.001) and SB showed a trend of being higher in males (♂4.4 ± 1.2 vs. ♀ 2.8 ± 0.84, p = 0.08); and for severe OSA, all questionnaires, apart from SB, were found to be higher in females (ESS: ♂ 9.5 ± 4.7 vs. ♀ 10.8 ± 4.7, p = 0.03; BQ: x 2 = 17.2, p = 0.001; AIS: ♂ 7.8 ± 5 vs. ♀ 10.2 ± 5.8, p = 0.05; STOP: ♂ 2.4 ± 0.84 vs. ♀ 2.83 ± 0.8, p < 0.001; FS: x 2 = 5.26, p = 0.02).

The proportion of Gram-negative bacteria showed a strong trend toward being higher in the Summer group (50.7%, 34/67) compared to the Winter group (35.1%, 20/57) (X 2 = 3.068, p = 0.080) ( Figure 1 ).

In patients with hepatic dysfunction, the active smoker group showed a trend towards more profound coagulopathy (mean INR 1.3 ± 0.2 vs. 1.2 ± 0.2, p = 0.08). 3.3.

However, plasma levels of Aβ 1-42 , t-Tau, and p-Tau181 showed an increasing trend in patients exhibiting a decrease in cognitive function (Aβ 1-42 : r = −0.832, p = 0.08; t-Tau: r = −0.932, p < 0.05; p-Tau181: r = −0.703, p = 0.185; Figure 2 b–d).

The difference between the CCT + sham group and other groups was not statistically significant immediately after the intervention [t(45.6) = 1.02, p = 0.57; d = 0.37], but it moved closer to significance at the 1-month follow-up [t(45.6) = 2.21, p = 0.08; d = 0.79].

Although there were no significant associations in the AA sibships likely due to the three-fold smaller sample, two SNPs (rs3764476 and rs3794884) were nearly significant (0.05 < p < 0.08) with effect directions matching those in the EUR sibships.

In the case of normalized ESR or CRP at 3 months, patients with normalized ESR or CRP at 3 months showed only a marginal significance in ASDAS-ID achievement (ESR, OR = 2.04; CI, 0.92–4.55; p = 0.080 and CRP, OR = 2.03; CI, 0.97–4.27; p = 0.060) ( Figure 3 A,C) but showed a significant difference in BASDAI-CRP attainment (ESR, OR = 3.29; CI, 1.42–7.46; p = 0.004 and CRP, OR = 2.73; CI, 1.32–5.62; p = 0.007), especially at 3 and 9 months (ESR: 3 months, p = 0.005; 9 months, p = 0.015 and CRP: 3 months, p < 0.001; 9 months, p = 0.021) ( Figure 3 B,D). 4.

0.38), with a trend toward significance in the between-group comparison ( p ≈ 0.08).

However, IL-13 shows a marginally non-significant difference ( t -test = 1.860, p = 0.080), with a large mean difference of 101.32, but it is still above the 0.05 significance threshold.

There was an association with marginal significance for HDL-C in models 1 and 2 (standardized β: 0.053, both p = 0.08).

However, a borderline significant difference was noted in the 10 yr probability of hip fracture, which was higher in the group with the elevated platelet count (7.4% vs. 4.5%, p = 0.08).

There was a significant increase in aldosterone and renin concentrations following a 120 min period of an upright posture (i.e., standing or sitting position), p < 0.0001; however, an overall suppression of aldosterone secretion was either not different after the first protocol versus the second protocol (6.34 ± 0.68 ng/dL (mean ± SEM) versus 5.74 ± 0.66 ng/dL, p = 0.124 (Mann–Whitney U test)) or showed a trend towards slightly lower values ( p = 0.08 for Wilcoxon test (mean ± SEM)).

However, in the multivariate linear mixed model, the relationship between preoperative IOP and IOP at 6 months post-surgery showed marginal significance with p = 0.08.

We could not detect any significant alterations within the 15-year observational period; however, there was a mild trend towards a shorter ICU stay over time (r = −0.093; p = 0.08).

The preoperative ejection fraction showed a trend to influence long-term outcome ( p = 0.08), but there were insufficient patients with a preoperative EF <40% in order to lend weight to this assumption.

In addition, our data suggested that time effect for EE approached significant level, Wilks’ Lambda = 0.89, F (1, 29) = 3.26, p = 0.08, η 2 = 0.08, indicating that overall, young children’s daily EE slightly improved from baseline to post-intervention with medium effect size.

However, in G, rCBV showed a trend toward a higher AUC than MET (0.736 vs. 0.612, p = 0.08).

Adults showed a trend toward higher baseline PGA scores compared with children (median PGA 5 (range 3–9) vs. 3 (range 2–9), p = 0.08). 4.3.1.

The ability of BA-clenching to assess AB-positive and AB-negative subjects was low but approaching significance (AUC of 0.604, p = 0.08).